No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Fatal Outcome
-
Female
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
-
Male
-
Middle Aged
-
Piperazines / therapeutic use*
-
Proto-Oncogene Proteins c-kit / analysis*
-
Pyrimidines / therapeutic use*
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Proto-Oncogene Proteins c-kit